Faculty Opinions recommendation of Src-induced de-regulation of E-cadherin in colon cancer cells requires integrin signalling.

Author(s):  
M Sharon Stack
PLoS ONE ◽  
2020 ◽  
Vol 15 (10) ◽  
pp. e0240746
Author(s):  
Lauren E. King ◽  
Hui-Hua Zhang ◽  
Cathryn M. Gould ◽  
Daniel W. Thomas ◽  
Lachlan W. Whitehead ◽  
...  

2011 ◽  
Vol 141 (6) ◽  
pp. 2140-2153 ◽  
Author(s):  
Amar B. Singh ◽  
Ashok Sharma ◽  
J. Joshua Smith ◽  
Moorthy Krishnan ◽  
Xi Chen ◽  
...  

Oncogene ◽  
2015 ◽  
Vol 35 (24) ◽  
pp. 3151-3162 ◽  
Author(s):  
Q Zhang ◽  
T Wei ◽  
K Shim ◽  
K Wright ◽  
K Xu ◽  
...  

Abstract Sprouty (SPRY) appears to act as a tumor suppressor in cancer, whereas we demonstrated that SPRY2 functions as a putative oncogene in colorectal cancer (CRC) (Oncogene, 2010, 29: 5241–5253). We investigated the mechanisms by which SPRY regulates epithelial–mesenchymal transition (EMT) in CRC. SPRY1 and SPRY2 mRNA transcripts were significantly upregulated in human CRC. Suppression of SPRY2 repressed AKT2 and EMT-inducing transcription factors and significantly increased E-cadherin expression. Concurrent downregulation of SPRY1 and SPRY2 also increased E-cadherin and suppressed mesenchymal markers in colon cancer cells. An inverse expression pattern between AKT2 and E-cadherin was established in a human CRC tissue microarray. SPRY2 negatively regulated miR-194-5p that interacts with AKT2 3′ untranslated region. Mir-194 mimics increased E-cadherin expression and suppressed cancer cell migration and invasion. By confocal microscopy, we demonstrated redistribution of E-cadherin to plasma membrane in colon cancer cells transfected with miR-194. Spry1 −/− and Spry2 −/− double mutant mouse embryonic fibroblasts exhibited decreased cell migration while acquiring several epithelial markers. In CRC, SPRY drive EMT and may serve as a biomarker of poor prognosis.


Author(s):  
Xiao Li ◽  
Wei Liu ◽  
Chong Geng ◽  
Tingting Li ◽  
Yanni Li ◽  
...  

Invasion and metastasis are the major causes leading to the high mortality of colon cancer. Ginsenoside Rg3 (Rg3), as a bioactive ginseng compound, is suggested to possess antimetastasis effects in colon cancer. However, the underlying molecular mechanisms remain unclear. In this study, we reported that Rg3 could effectively inhibit colon cancer cell invasion and metastasis through in vivo and in vitro studies. In addition, Rg3 suppressed the epithelial–mesenchymal transition (EMT) of HCT15 cells and SW48 cells evidenced by detecting EMT related markers E-cadherin, vimentin, and snail expression. Furthermore, inhibition of Notch signaling by LY411,575 or specific Hes1 siRNA obviously repressed colon cancer cell migration and metastasis, and induced increase in E-cadherin and decrease in vimentin and snail. Meanwhile, the expression of NICD and Hes1 was obviously decreased in the presence of Rg3. However, Rg3 failed to suppress EMT in Hes1 overexpressed colon cancer cells. In particular, Rg3 significantly reversed IL-6-induced EMT promotion and blocked IL-6- induced NICD and Hes1 upregulations. Overall, these findings suggested that Rg3 could inhibit colon cancer migration and metastasis via suppressing Notch-Hes1-EMT signaling.


2016 ◽  
Vol 33 (3) ◽  
Author(s):  
Lin Zha ◽  
Qiang Cao ◽  
Xin Cui ◽  
Fenfen Li ◽  
Houjie Liang ◽  
...  

2019 ◽  
Vol 110 (11) ◽  
pp. 3520-3532 ◽  
Author(s):  
Yamin Qian ◽  
Xin Wu ◽  
Yuhki Yokoyama ◽  
Daisuke Okuzaki ◽  
Mai Taguchi ◽  
...  

Oncogene ◽  
2017 ◽  
Vol 37 (5) ◽  
pp. 663-672 ◽  
Author(s):  
F A Benthani ◽  
D Herrmann ◽  
P N Tran ◽  
L Pangon ◽  
M C Lucas ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document